Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer - Wikidata - wikimedia - TriplyDB

Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer

Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer

http://www.wikidata.org/entity/Q24658328

about

Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221 Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation Argonaute proteins: potential biomarkers for human colon cancer The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer.The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues.Tudor-SN Interacts with Piwi Antagonistically in Regulating Spermatogenesis but Synergistically in Silencing Transposons in Drosophila.Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.Identification of p100 target promoters by chromatin immunoprecipitation-guided ligation and selection (ChIP-GLAS).miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells.Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11 The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.Tudor staphylococcal nuclease: biochemistry and functions MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma.Prognostic impact of Metadherin-SND1 interaction in colon cancer.Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.SREBP-2-driven transcriptional activation of human SND1 oncogene.Tudor staphylococcal nuclease is a structure-specific ribonuclease that degrades RNA at unstructured regions during microRNA decay.SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.miR-361-5p inhibits glioma migration and invasion by targeting SND1

P2860

Q24339199-FC76FB4E-FA14-4566-9CC9-BD02CAF272E0 Q24631381-5CA48613-044C-4A0E-AD5A-EE441BF840A9 Q28241756-0E04F48B-BE0D-4707-B46A-CF471EF9F633 Q28247786-1AF04B0B-2510-4937-B5BE-E3693D0AAB93 Q28394324-36BA2607-11D2-48F8-821D-5331518F323C Q28480605-2D0545D4-752D-4266-9413-E5A1A8163EDB Q33530549-424AABBB-8205-490C-A1ED-7544FB6101C8 Q33633347-B588C9DF-3FBE-4E85-AD23-E9F1247A96EF Q34775841-4893E741-63A2-497A-B24E-2B4CA4EB4C7F Q35033626-15FF2834-6B93-4FDD-9478-4F51C70CB934 Q35508316-ABBD777E-D731-4236-B34D-67178A73C59F Q35745008-25C4761D-5537-4F4B-97A7-52EE2784B7F8 Q35903790-A559FD0C-F031-4BF0-9B6F-97FE1CAABCE1 Q36584345-0BFE3238-C422-488E-8C02-8E2330D85D80 Q36898265-518C409E-1F02-4A93-81E5-696335BD604B Q37445217-380C25E4-4DE6-4A21-9571-0794D30CD369 Q37729241-1A895996-D60A-47EB-8EE6-B9FF4B9C5489 Q37746117-6D2BF168-6CA2-4EF0-A50E-3E5A2B4D3F17 Q38296730-6ADE6DE2-A68B-49BC-A2A1-0B74CBA6C1D6 Q38879143-D1126F61-BE6E-4AAB-9489-8B81638689A9 Q38925261-E476E763-EB1B-4B8E-AEDD-C9405AB77436 Q38950232-78DFF778-D2C7-41D0-9376-52C3954DC62A Q39071870-EDEB6417-402C-4771-B894-4619CFC78C1D Q39101578-6E9D67EE-1452-432F-84CF-DF9A214BDF0C Q39121577-8BC368AB-A05E-49A4-8BE3-2EF83BE2F51E Q41667684-0175F80A-6615-4E3E-BDE3-73B9133A8DB3 Q43604730-6F0574D7-F40B-4F42-99A7-AA91D902F575 Q45057498-D3CDCD43-7988-4504-9A21-58D38F6462AD Q47094029-0C4E2F57-74ED-44CE-9EAD-AFE87736DFE1 Q50026959-F26B55E8-0BD9-4DE0-9030-720E5E37C4AC Q51109576-64EB3CA9-FE64-45C0-AAC3-5AA9EB4D5D47 Q58698576-70566E13-E292-4F0C-9C64-A9927C26E6A2

P2860

Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer

http://www.wikidata.org/entity/Q24658328

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@ast

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@en

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@nl

type

label

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@ast

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@en

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@nl

prefLabel

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@ast

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@en

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@nl

P1433

Q24658328-DFD01673-D092-481C-8F6D-5B50E8766299

P1476

Q24658328-BE4A4E87-1225-4E8F-AF88-5867312B1D56

P2093

Q24658328-05A9FFE7-9CFC-43A3-A5AE-7A38F5B44819

Q24658328-23000BA1-AD34-4755-9F5A-0B3FEABDA97C

Q24658328-2DDF8568-1881-445A-8230-ACCEA7D80098

Q24658328-6A8A23E5-0C1D-4378-922D-C34FA0297F18

Q24658328-7DA59A76-0350-479F-B8E8-250F9C655002

Q24658328-90D1138A-4C40-44CA-BD5B-4ADA353012C4

Q24658328-9D94C819-92E7-4661-AF25-3F720ABEE19A

Q24658328-A1A0D50E-BD0B-47DC-A39D-4B9580A80F84

Q24658328-AE77E7BB-F3CE-47B0-8FA2-683932FF8D79

P2860

Q24658328-09289B56-A943-4E3F-9B13-38CB718D0C93

Q24658328-0C995B94-59D8-4D7D-B470-131D998E86DF

Q24658328-15CCA8B2-A040-4D84-88C8-1F29699EF60B

Q24658328-1F850D62-D160-4D1B-BED5-E2BBEC5D57CE

Q24658328-205A2F90-C38F-408D-8C5F-6F824FA67A33

Q24658328-28FD58EE-EF85-4995-A07B-FCACFD01C43F

Q24658328-2D24A8EC-834B-403F-BFE9-62A40A3B1DC4

Q24658328-43D41065-A14B-4573-A749-64996110677A

Q24658328-4ED94268-C093-472E-B922-DA51C9E29034

Q24658328-52096A4B-2F54-4498-A1DE-6F699EFF121F

P304

Q24658328-6C1B232D-CB6A-4D43-B5EB-BC2F8D6BDAAA

P31

Q24658328-D1BF8533-F91B-4450-A66F-976DAE52D303

P3181

Q24658328-E606D4FB-F7F8-49DB-88D3-B608AD01EDE3

P356

Q24658328-171BCCD5-D5AA-4FEC-B374-8C89C16F37F6

P407

Q24658328-17CB0AF4-B994-4EA7-819E-F430696DA6C8

P433

Q24658328-19C1B24E-40C2-4AFD-85EE-CD261F92444C

P478

Q24658328-2766269F-5C5A-43DF-85C6-1F33521C527D

P50

Q24658328-4BFAE727-2556-4721-8F04-94385F0FA30C

P577

Q24658328-B698305A-98F5-439C-BCAC-E384A06BCF3F

P5875

Q24658328-0ABD39FD-EE7F-4EB7-82B6-1DDC8C4C8053

P698

Q24658328-0ECCA27D-AAA9-42DB-BB6E-EA6468F91A58

P932

Q24658328-9D4ADF5C-3921-4615-969A-79C346CCEADC

P3181

P356

AJPATH.2009.080776

P1433

The American Journal of Pathology

P1476

Staphylococcal nuclease domain ...... sue marker for prostate cancer

@en

P2093

Hidetoshi Kuruma

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sasaki

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Takahashi

http://www.w3.org/2001/XMLSchema#string

Jun Miki

http://www.w3.org/2001/XMLSchema#string

Kenta Miki

http://www.w3.org/2001/XMLSchema#string

Norihiro Hayashi

http://www.w3.org/2001/XMLSchema#string

Shin Egawa

http://www.w3.org/2001/XMLSchema#string

Takahiro Kimura

http://www.w3.org/2001/XMLSchema#string

Yuko Kamata

http://www.w3.org/2001/XMLSchema#string

P2860

The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE

The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development

Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

A microRNA expression signature of human solid tumors defines cancer gene targets

Role for a bidentate ribonuclease in the initiation step of RNA interference

SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis

Pim-1 kinase and p100 cooperate to enhance c-Myb activity

Myb binding proteins: regulators and cohorts in transformation.

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma

P304

2044-2050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4849458

http://www.w3.org/2001/XMLSchema#string

P356

10.2353/AJPATH.2009.080776

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24421221

http://www.w3.org/2001/XMLSchema#string

P698

19435788

http://www.w3.org/2001/XMLSchema#string

P932

2684170

http://www.w3.org/2001/XMLSchema#string